Ginsenoside Rb1: The new treatment measure of myasthenia gravis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ginsenoside Rb1: The new treatment measure of myasthenia gravis

Published:2016-12 Issue: Volume:41 Page:136-143
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Chen Wei,Meng Qing-Fang,Sui Jun-Kang,Wang Yan-Jun,Li Xiao-Li,Liu Shen,Li Heng,Wang Cong-Cong,Li Chun-Hong,Li Yan-Bin

Funder

Shandong Provincial Natural Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference73 articles.

1. Complement regulatory protein Crry deficiency contributes to the antigen specific recall response in experimental autoimmune myasthenia gravis;Soltys;J. Inflamm. (Lond.),2012

2. Atorvastatin-modified dendritic cells in vitro ameliorate experimental autoimmune myasthenia gravis by up-regulated Treg cells and shifted Th1/Th17 to Th2 cytokines;Li;Mol. Cell. Neurosci.,2013

3. Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?;Baggi;Arch. Immunol. Ther. Exp.,2012

4. Disorders of neuromuscular junction ion channels;Boonyapisit;Am. J. Med.,1999

5. Breakdown of tolerance to a self-peptide of acetylcholine receptor α-subunit induces experimental myasthenia gravis in rats;Baggi;J. Immunol.,2004

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical remission of moderate generalized myasthenia gravis through exclusive use of Buzhong Yiqi decoction: A case report;EXPLORE;2024-07

2. Multi-layered effects of Panax notoginseng on immune system;Pharmacological Research;2024-06

3. Elucidation of Immune Regulation Mechanism of Renshen Guben Oral Liquid by Network Pharmacology and Molecular Docking;World Journal of Traditional Chinese Medicine;2023

4. Biopharmaceutical characters and bioavailability improving strategies of ginsenosides;Fitoterapia;2018-09

5. Chinese Herbal Medicine for Myasthenia Gravis: A Systematic Review and Meta-Analysis;Frontiers in Pharmacology;2018-08-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3